E-LIB Suche - Ergebnisse für: Grumberg, Valentine

1

Outcome following nivolumab treatment in patients with adva..:

Assié, Jean-Baptiste ; Chouaïd, Christos ; Nunes, Hilario...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. 175883592311528 , 2023

Link: https://doi.org/10.1177/..

2

Characteristics, management, and healthcare resources of pa..:

Assié, Jean-Baptiste ; Grumberg, Valentine ; Reynaud, Dorothée...
Respiratory Medicine and Research. 84 (2023) - p. 101051 , 2023

Link: https://doi.org/10.1016/..

3

A Review of Overall Survival Extrapolations of Immune-Check..:

Grumberg, Valentine ; Roze, Stéphane ; Chevalier, Julie...
International Journal of Technology Assessment in Health Care. 38 (2022) 1 - p. , 2022

Link: https://doi.org/10.1017/..

4

Long-term hospital resource utilization and associated cost..:

Grumberg, Valentine ; Chouaïd, Christos ; Cotté, François-Emery...
Journal of Medical Economics. 25 (2022) 1 - p. 691-699 , 2022

Link: https://doi.org/10.1080/..

5

A Review of Overall Survival Extrapolations of Immune-Check..:

Grumberg, Valentine ; Roze, Stéphane ; Chevalier, Julie...
International Journal of Technology Assessment in Health Care. 38 (2022) 1 - p. , 2022

Link: https://doi.org/10.1017/..

6

Nivolumab treatment in advanced non-small cell lung cancer:..:

Assié, Jean-Baptiste ; Corre, Romain ; Levra, Matteo Giaj...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883592096723 , 2020

Link: https://doi.org/10.1177/..

7

Immunotherapy rechallenge after nivolumab treatment in adva..:

Giaj Levra, Matteo ; Cotté, François-Emery ; Corre, Romain...
Lung Cancer. 140 (2020) - p. 99-106 , 2020

Link: https://doi.org/10.1016/..

8

Outcome following nivolumab treatment in patients with adva..:

Assié, Jean-Baptiste ; Chouaïd, Christos ; Nunes, Hilario...
info:eu-repo/semantics/altIdentifier/doi/10.1177/17588359231152847. , 2023

Link: https://hal.u-pec.fr/hal..

9

Organizational Impact of Immunotherapies in Advanced Cancer..:

Grumberg, Valentine ; Chouaïd, Christos ; Gaudin, Anne Françoise...
info:eu-repo/semantics/altIdentifier/doi/10.1200/GO.23.00026. , 2023

Link: https://hal.science/hal-..

10

Organizational Impact of Immunotherapies in Advanced Cancer..:

Grumberg, Valentine ; Chouaïd, Christos ; Gaudin, Anne Françoise...
info:eu-repo/semantics/altIdentifier/doi/10.1200/GO.23.00026. , 2023

Link: https://hal.science/hal-..

11

Outcome following nivolumab treatment in patients with adva..:

Assié, Jean-Baptiste ; Chouaïd, Christos ; Nunes, Hilario...
info:eu-repo/semantics/altIdentifier/doi/10.1177/17588359231152847. , 2023

Link: https://hal.u-pec.fr/hal..

12

Characteristics, management, and healthcare resources of pa..:

Assié, Jean Baptiste ; Grumberg, Valentine ; Reynaud, Dorothée...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.resmer.2023.101051. , 2023

Link: https://hal.science/hal-..

13

Characteristics, management, and healthcare resources of pa..:

Assié, Jean Baptiste ; Grumberg, Valentine ; Reynaud, Dorothée...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.resmer.2023.101051. , 2023

Link: https://hal.science/hal-..

14

Outcome following nivolumab treatment in patients with adva..:

Assié, Jean-Baptiste ; Chouaïd, Christos ; Nunes, Hilario...
info:eu-repo/semantics/altIdentifier/doi/10.1177/17588359231152847. , 2023

Link: https://hal.u-pec.fr/hal..

15

Characteristics, management, and healthcare resources of pa..:

Assié, Jean Baptiste ; Grumberg, Valentine ; Reynaud, Dorothée...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.resmer.2023.101051. , 2023

Link: https://hal.science/hal-..